Figure 6
From: Targeting the CXCR4/CXCL12 axis with the peptide antagonist E5 to inhibit breast tumor progression
Western blot analysis of CD31, CXCR4, and Akt and Erk phosphorylation in tumors of mice treated with either E5 or E5 combined with paclitaxel (PTX) or cyclophosphamide (CTX).
